Daniel M. Bendheim
2021
In 2021, Daniel M. Bendheim earned a total compensation of $758.5K as Director and Executive Vice President, Corporate Strategy at Phibro Animal Health, a 18% increase compared to previous year.
Compensation breakdown
| Change in Pension Value and Nonqualified Deferred Compensation Earnings | $22,895 |
|---|---|
| Non-Equity Incentive Plan | $274,906 |
| Salary | $430,000 |
| Other | $30,723 |
| Total | $758,524 |
Bendheim received $430K in salary, accounting for 57% of the total pay in 2021.
Bendheim also received $22.9K of change in pension value and nonqualified deferred compensation earnings, $274.9K in non-equity incentive plan and $30.7K in other compensation.
Rankings
In 2021, Daniel M. Bendheim's compensation ranked 9,646th out of 12,405 executives tracked by ExecPay. In other words, Bendheim earned more than 22.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,646 out of 12,405 | 22nd |
Division Manufacturing | 4,268 out of 5,494 | 22nd |
Major group Chemicals And Allied Products | 1,889 out of 2,369 | 20th |
Industry group Drugs | 1,675 out of 2,090 | 20th |
Industry Pharmaceutical Preparations | 1,244 out of 1,537 | 19th |
Source: SEC filing on September 16, 2022.
Bendheim's colleagues
We found four more compensation records of executives who worked with Daniel M. Bendheim at Phibro Animal Health in 2021.